Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
TKO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
-9%
1.05
vs 1.15
Q2.23
-15%
0.91
vs 1.07
Q3.23
-66%
0.52
vs 1.55
Q4.23
N/A
-0.09
vs 0.77
Q1.24
+104%
2.14
vs 1.05
Q2.24
-21%
0.72
vs 0.91
Q3.24
+2%
0.53
vs 0.52
Q4.24
+489%
0.35
vs -0.09
Q1.25
-73%
0.58
vs 2.14
Q2.25
+66%
1.2
vs 0.72
Sales Growth
YoY
Current
Estimates
Q1.23
+18%
306.7M vs 259.6M
Q2.23
+14%
305.2M vs 268.1M
Q3.23
+32%
449.1M vs 340.7M
Q4.23
+126%
614M vs 271.8M
Q1.24
+105%
629.7M vs 306.7M
Q2.24
+179%
851.2M vs 305.2M
Q3.24
+52%
681.3M vs 449.1M
Q4.24
+5%
642.2M vs 614M
Q1.25
+12%
703.6M vs 629.7M
Q2.25
+6%
904M vs 851.2M
Return on Equity
QoQ
Q1.23
+16%
0.16
vs 0.12
Q2.23
+14%
0.14
vs 0.16
Q3.23
+1%
0.01
vs 0.14
Q4.23
0%
-0.00
vs 0.01
Q1.24
-3%
-0.03
vs -0.00
Q2.24
+1%
0.01
vs -0.03
Q3.24
+1%
0.01
vs 0.01
Q4.24
+1%
0.01
vs 0.01
Institutionnal Ownership
QoQ
Q2.18
1
1
vs 1
NA
Q3.18
1
1
vs 1
NA
Q3.23
332
332
vs NA
NA
Q4.23
351
351
vs 332
6%
Q1.24
372
372
vs 351
6%
Q2.24
391
391
vs 372
5%
Q3.24
434
434
vs 391
11%
Q4.24
492
492
vs 434
13%
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
174.67(17.06%)
Number of analyst
3
Last analyst upgrade/downgrade
Benchmark
downgradePrevious: Not converted
2024-10-24
Now: Hold
Pivotal Research
initialisePrevious: Not converted
2024-09-13
Now: Buy
Cowen & Co.
upgradePrevious: Not converted
2024-05-15
Now: Buy
Argus Research
initialisePrevious: Not converted
2023-10-02
Now: Buy
seekingalpha.com
5 hours ago
businesswire.com
8 hours ago
businesswire.com
8 hours ago
globenewswire.com
8 hours ago
businesswire.com
11 hours ago
investopedia.com
12 hours ago
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How TKO compares to sector?
TKO
1291x
Relative Strength
TKO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|